Abstract
Endothelium-derived vascular relaxing factor (EDRF)1 is a humoral agent that is released by vascular endothelium and mediates vasodilator responses induced by various substances including acetylcholine and bradykinin2. EDRF is very unstable, with a half-life of between 6 (refs 3, 4) and 50 (ref. 5) s, and is clearly distinguishable from prostacyclin6. The chemical structure of EDRF is unknown but it has been suggested that it is either a hydroperoxy- or free radical-derivative of arachidonic acid or an unstable aldehyde, ketone or lactone3. We have examined the role of superoxide anion (O2−) in the inactivation of EDRF released from vascular endothelial cells cultured on microcarrier beads and bioassayed using a cascade of superfused aortic smooth muscle strips7. With this system, we have now demonstrated that EDRF is protected from breakdown by superoxide dismutase (SOD) and Cu2+, but not by catalase, and is inactivated by Fe2+. These findings indicate that O2− contributes significantly to the instability of EDRF.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
196,21 € per year
only 3,85 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Furchgott, R. F. & Zawadzki, J. V. Nature 288, 373–376 (1980).
Furchgott, R. F. A. Rev. Pharmac. Tox. 24, 175–197 (1984).
Griffith, T. M., Edwards, D. H., Lewis, M. J., Newby, A. C. & Henderson, A. H. Nature 308, 645–647 (1984).
Cocks, T. M., Angus, J. A., Campbell, J. H. & Campbell, G. R. J. cell. Physiol. 123, 310–320 (1985).
Förstermann, U., Trogisch, G. & Busse, R. Eur. J. Pharmac. 106, 639–643 (1985).
Moncada, S., Gryglewski, R. J., Bunting, S. & Vane, J. R. Nature 263, 663–665 (1976).
Gryglewski, R. J., Moncada, S. & Palmer, R. M. J. Br. J. Pharmac. 87, 685–694 (1986).
Vane, J. R. Br. J. Pharmac. Chemother. 23, 360–373 (1964).
Rapaport, R. M., Drazin, M. B. & Murad, F. Nature 306, 174–176 (1983).
Martin, W., Villani, G. M., Jothianandan, D. & Furchgott, R. F. J. Pharmac. exp. Ther. 232, 708–716 (1985).
Keele, B. B., McCord, J. M. & Fridovich, I. J. biol Chem. 246, 2875–2880 (1971).
Heikkila, R. E. & Cohen, G. in Superoxide and Superoxide Dismutases (eds Michelson, A. M., McCord, J. M. & Fridovich, I.) 367–373 (Academic, London, 1977).
Block, E. R., Patel, J. M. & Sheridan, N. P. J. cell Physiol. 122, 240–248 (1985).
Epel, B. L. & Neumann, J. Biochim. biophys. Acta. 325, 520–529 (1973).
Lumsden, J. & Hall, D. C. Biochem. biophys. Res. Commun. 64, 595–602 (1975).
Michelson, A. M. in Superoxide and Superoxide Dismutases (eds Michelson, A. M., McCord, J. M. & Fridovich, I.) 77–86 (Academic, London, 1977).
Freeman, B. A. & Crapo, J. D. Lab. Invest. 47, 412–426 (1982).
Moncada, S., Gryglewski, R. J., Bunting, S. & Vane, J. R. Prostaglandins. 12, 715–733 (1976).
Vanhoutte, P. M. & Rubanyi, G. M. Clin. Res. 33, 523A (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gryglewski, R., Palmer, R. & Moncada, S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320, 454–456 (1986). https://doi.org/10.1038/320454a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/320454a0